DE60336509D1 - Zubereitungen enthaltend sincalide - Google Patents
Zubereitungen enthaltend sincalideInfo
- Publication number
- DE60336509D1 DE60336509D1 DE60336509T DE60336509T DE60336509D1 DE 60336509 D1 DE60336509 D1 DE 60336509D1 DE 60336509 T DE60336509 T DE 60336509T DE 60336509 T DE60336509 T DE 60336509T DE 60336509 D1 DE60336509 D1 DE 60336509D1
- Authority
- DE
- Germany
- Prior art keywords
- sincalide
- preparations containing
- methods
- formulations
- sincalide formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/222,540 US6803046B2 (en) | 2002-08-16 | 2002-08-16 | Sincalide formulations |
PCT/IB2003/006513 WO2005027954A2 (en) | 2002-08-16 | 2003-08-15 | Sincalide formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60336509D1 true DE60336509D1 (de) | 2011-05-05 |
Family
ID=31714996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60336509T Expired - Lifetime DE60336509D1 (de) | 2002-08-16 | 2003-08-15 | Zubereitungen enthaltend sincalide |
Country Status (9)
Country | Link |
---|---|
US (13) | US6803046B2 (de) |
EP (1) | EP1631305B1 (de) |
JP (1) | JP4751993B2 (de) |
CN (1) | CN100374154C (de) |
AT (1) | ATE502647T1 (de) |
AU (1) | AU2003304382B2 (de) |
CA (1) | CA2503982C (de) |
DE (1) | DE60336509D1 (de) |
WO (1) | WO2005027954A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502116A (ja) * | 2002-07-12 | 2006-01-19 | メダレックス, インク. | タンパク質の酸化分解を防ぐ方法及び組成物 |
US6803046B2 (en) * | 2002-08-16 | 2004-10-12 | Bracco International B.V. | Sincalide formulations |
US20050256097A1 (en) * | 2004-05-11 | 2005-11-17 | Kosan Biosciences, Inc. | Pharmaceutical solution formulations containing 17-AAG |
US20070243264A1 (en) * | 2006-04-18 | 2007-10-18 | Aram Garabedian | Thickened Dilute Hypochlorite |
US7923425B2 (en) * | 2006-08-21 | 2011-04-12 | Henkel Ag & Co. Kgaa | Low-foaming, acidic low-temperature cleaner and process for cleaning surfaces |
ES2624960T3 (es) | 2006-09-29 | 2017-07-18 | Johnson & Johnson Vision Care, Inc. | Método de fabricación de dispositivos oftálmicos usados en el tratamiento de alergias oculares |
JP2010506129A (ja) * | 2006-10-03 | 2010-02-25 | ワイス エルエルシー | 凍結乾燥法および装置 |
MX2009005644A (es) * | 2006-12-22 | 2009-06-08 | Sigma Tau Ind Farmaceuti | Gel util para el suministro de farmacos oftalmicos. |
EP2170400B1 (de) | 2007-07-10 | 2012-07-25 | Medy-Tox, INC. | Pharmazeutische flüssige zusammensetzung von botulinustoxin mit verbesserter stabilität |
US9801818B2 (en) | 2007-12-31 | 2017-10-31 | Samyang Biopharmaceuticals Corporation | Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug |
EP2236520A1 (de) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Stabilisierungszusammensetzung für immobilisierte Biomoleküle |
CN103027890B (zh) * | 2011-09-29 | 2014-06-18 | 天津市汉康医药生物技术有限公司 | 供注射用的布洛芬药物组合物 |
US9636407B2 (en) | 2012-11-20 | 2017-05-02 | Fresenius Kabi Usa, Llc | Caspofungin acetate formulations |
HUE030221T2 (en) | 2014-03-31 | 2017-04-28 | Vasopharm Gmbh | Solid pharmaceutical composition containing biopterin derivatives and uses of such compositions |
CN104761645A (zh) * | 2015-04-30 | 2015-07-08 | 山东禹王制药有限公司 | α干扰素融合蛋白制剂及应用 |
JP6491747B2 (ja) | 2015-09-30 | 2019-03-27 | デューク・ユニヴァーシティ | 磁気共鳴画像法用の造影剤 |
US20180360917A1 (en) * | 2017-06-15 | 2018-12-20 | Apicore Llc | Sincalide formulations and methods of use |
US11110063B2 (en) * | 2017-08-25 | 2021-09-07 | MAIA Pharmaceuticals, Inc. | Storage stable sincalide formulations |
JP7183268B2 (ja) * | 2017-11-20 | 2022-12-05 | ジャスト-エヴォテック バイオロジックス、インコーポレイテッド | 等張化剤としてリジン塩を含有するアフリベルセプト製剤及びその使用 |
US11809191B2 (en) | 2020-09-29 | 2023-11-07 | Topcon Positioning Systems, Inc. | Maneuvering system for autonomous wheeled robot for optimally reaching starting point |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3723406A (en) | 1969-12-23 | 1973-03-27 | Squibb & Sons Inc | Novel peptides having cholecystokinin activity and intermediates therefor |
US3937819A (en) * | 1974-07-22 | 1976-02-10 | E. R. Squibb & Sons, Inc. | Method of stabilizing an injectable composition of a cholecystokinin active octapeptide |
IT1204430B (it) * | 1986-01-10 | 1989-03-01 | Alfio Bertolini | Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria |
US5011678A (en) * | 1989-02-01 | 1991-04-30 | California Biotechnology Inc. | Composition and method for administration of pharmaceutically active substances |
CA2028848A1 (en) * | 1989-04-11 | 1990-10-12 | Tapan Audhya | Lyophilized peptide formulations |
IN172208B (de) | 1990-04-02 | 1993-05-01 | Sint Sa | |
US5556610A (en) * | 1992-01-24 | 1996-09-17 | Bracco Research S.A. | Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method |
TW274552B (de) * | 1992-05-26 | 1996-04-21 | Hoechst Ag | |
US5373613A (en) | 1992-10-23 | 1994-12-20 | Young Engineering, Inc. | Tenter frame with pinned roll transfer means |
JPH06273415A (ja) * | 1993-03-18 | 1994-09-30 | Unitika Ltd | コレシストキニンの測定用試薬及び測定方法 |
GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
FR2719479B1 (fr) * | 1994-05-04 | 1996-07-26 | Sanofi Elf | Formulation stable lyophilisée comprenant une protéine: kit de dosage. |
US5676950A (en) * | 1994-10-28 | 1997-10-14 | University Of Florida | Enterically administered recombinant poxvirus vaccines |
US5833948A (en) | 1995-06-15 | 1998-11-10 | Bracco Research S.A. | Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant |
DE19645250A1 (de) | 1996-11-02 | 1998-05-07 | Merck Patent Gmbh | Stabile wäßrige Formulierung von 3-(N-Butylacetamino)-propionsäureethylester |
CH692322A5 (it) | 1997-05-26 | 2002-05-15 | Westy Ag | Formulazione iniettabile limpida di Propofol. |
ATE310501T1 (de) * | 1998-12-09 | 2005-12-15 | Chiron Corp | Verabreichung von neurotropischen wirkstoffen in das zentrale nervensystem |
JP2000247903A (ja) * | 1999-03-01 | 2000-09-12 | Chugai Pharmaceut Co Ltd | 長期安定化製剤 |
SE9901578D0 (sv) * | 1999-05-03 | 1999-05-03 | Karolinska Innovations Ab | New use of substance in PNS |
US6440414B1 (en) * | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
US6579521B2 (en) * | 2000-10-20 | 2003-06-17 | Chiron Corporation | Methods of therapy for HIV infection |
US6803046B2 (en) * | 2002-08-16 | 2004-10-12 | Bracco International B.V. | Sincalide formulations |
-
2002
- 2002-08-16 US US10/222,540 patent/US6803046B2/en not_active Expired - Lifetime
-
2003
- 2003-08-15 WO PCT/IB2003/006513 patent/WO2005027954A2/en active Application Filing
- 2003-08-15 AT AT03818433T patent/ATE502647T1/de not_active IP Right Cessation
- 2003-08-15 CN CNB038241374A patent/CN100374154C/zh not_active Expired - Lifetime
- 2003-08-15 DE DE60336509T patent/DE60336509D1/de not_active Expired - Lifetime
- 2003-08-15 AU AU2003304382A patent/AU2003304382B2/en not_active Expired
- 2003-08-15 EP EP03818433A patent/EP1631305B1/de not_active Expired - Lifetime
- 2003-08-15 JP JP2005509018A patent/JP4751993B2/ja not_active Expired - Lifetime
- 2003-08-15 CA CA2503982A patent/CA2503982C/en not_active Expired - Lifetime
-
2004
- 2004-08-19 US US10/921,732 patent/US20050020502A1/en not_active Abandoned
-
2009
- 2009-10-28 US US12/607,337 patent/US20100047175A1/en not_active Abandoned
-
2011
- 2011-12-02 US US13/309,848 patent/US20120128581A1/en not_active Abandoned
-
2013
- 2013-10-28 US US14/064,379 patent/US20140065071A1/en not_active Abandoned
-
2014
- 2014-10-02 US US14/504,498 patent/US20150017097A1/en not_active Abandoned
-
2015
- 2015-04-27 US US14/696,658 patent/US20150224166A1/en not_active Abandoned
-
2016
- 2016-09-30 US US15/281,489 patent/US20170014470A1/en not_active Abandoned
-
2017
- 2017-05-05 US US15/587,471 patent/US20170281719A1/en not_active Abandoned
- 2017-11-08 US US15/807,555 patent/US20180064781A1/en not_active Abandoned
-
2019
- 2019-10-01 US US16/589,230 patent/US20200030406A1/en not_active Abandoned
-
2020
- 2020-04-27 US US16/858,815 patent/US20200254052A1/en not_active Abandoned
- 2020-10-01 US US17/060,191 patent/US20210093689A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20120128581A1 (en) | 2012-05-24 |
US20050020502A1 (en) | 2005-01-27 |
CN1756557A (zh) | 2006-04-05 |
US20200254052A1 (en) | 2020-08-13 |
EP1631305B1 (de) | 2011-03-23 |
EP1631305A2 (de) | 2006-03-08 |
ATE502647T1 (de) | 2011-04-15 |
AU2003304382B2 (en) | 2008-11-06 |
US20100047175A1 (en) | 2010-02-25 |
US20040033243A1 (en) | 2004-02-19 |
JP2006515321A (ja) | 2006-05-25 |
CA2503982A1 (en) | 2005-03-31 |
CA2503982C (en) | 2011-09-27 |
US20140065071A1 (en) | 2014-03-06 |
CN100374154C (zh) | 2008-03-12 |
US20200030406A1 (en) | 2020-01-30 |
US20150017097A1 (en) | 2015-01-15 |
US20150224166A1 (en) | 2015-08-13 |
US6803046B2 (en) | 2004-10-12 |
US20170281719A1 (en) | 2017-10-05 |
WO2005027954A3 (en) | 2005-10-20 |
WO2005027954A2 (en) | 2005-03-31 |
US20180064781A1 (en) | 2018-03-08 |
AU2003304382A1 (en) | 2005-04-28 |
US20210093689A1 (en) | 2021-04-01 |
US20170014470A1 (en) | 2017-01-19 |
JP4751993B2 (ja) | 2011-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE502647T1 (de) | Zubereitungen enthaltend sincalide | |
IL138476A0 (en) | Method for treating pharmaceutical compositions by special use of anti-oxidant | |
IS6950A (is) | Samsetning epóþílonhliðstæðna og efnameðferðarlyfja til meðhöndlunar frumufjölgunarsjúkdóma | |
CY1111872T1 (el) | Συνθεσεις υποτασικου λιπιδιου (προσταγλανδινης) και τιμολολης - σχετικες μεθοδοι χρησης | |
AU2002360488A8 (en) | Methods and devices for detection and therapy of atheromatous plaque | |
DK1718677T3 (da) | Monovalente antistoffragmenter egnede som terapeutiske midler | |
MXPA03011006A (es) | Compuestos de cicloalquil urea benzo-fusionados 1,4-disustituidos. | |
ATE289640T1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
NO20042964L (no) | Spiroazasykliske forbindelser som monoaminreseptormodulatorer | |
ATE504315T1 (de) | Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen | |
TR200003036T2 (tr) | 12,13-Modifiye edilmiş epotilon türevleri | |
DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
MXPA04001224A (es) | Agentes para incrementar la respuesta inmune. | |
AU3831301A (en) | Method for treating ocular pain | |
WO2001044247A3 (en) | Agents and methods for the treatment of proliferative diseases | |
CY1107531T1 (el) | Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου | |
NO20043013L (no) | Tetrahydrokinolin analoger som muskarine agonister | |
BRPI0412971A (pt) | método de alongamento do cabelo | |
BR0213072A (pt) | Sabonete em barra | |
BR0011225A (pt) | Agente para tratar de olhos secos, seu método e uso | |
ATE443044T1 (de) | Tace inhibitoren | |
NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
DE60213802D1 (de) | Cak inhibitoren und deren verwendungen | |
ITRM20000266A0 (it) | Procedimento migliorato per la preparazione di (e,z) 3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi. | |
TW200512009A (en) | Hair treatment compositions |